Prospective G7 Dual Mobility Total Hip PMCF
← catalyst calendarNCT03308929 · readout in 316 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
250estimated
Sites
6
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2017-02-28 | actual | When the study began enrolling |
| Primary completion | 2027-07-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-02-28 | estimated | The whole study's end, after follow-up |
| First posted | 2017-10-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-06-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Clinical Outcomes
- Functional Outcomes
- Radiological Outcomes
- Survivorship
- Safety
Intervention
- Device: G7 Dual Mobility hip
Primary outcome
what the primary-completion date above is the date OFSurvivorship of the study device
measured 5 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed